Expanding upon the pathophysiology of MASLD through study 2, we further show that MASLD is characterized by higher total but not H-specific GDF15 levels following an OGTT, whereas GIP and C-peptide remain unaffected. The gene discussed is GIP; the disease is metabolic dysfunction-associated steatotic liver disease.